About Merz Therapeutics
Merz Therapeutics is a company based in Frankfurt (Germany). It operates as a Professional Services, and Reseller / Distribution. Merz Therapeutics has completed 1 acquisition, including Acorda. Merz Therapeutics offers products and services including Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies. Merz Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Incyte, NGM Biopharmaceuticals and Neurocrine, among others.
- Headquarter Frankfurt, Germany
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Merz Therapeutics Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Merz Therapeutics
Merz Therapeutics offers a comprehensive portfolio of products and services, including Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for movement disorders are developed and provided.
Solutions for liver-related conditions are researched and offered.
Products for skin conditions are formulated and distributed.
Specialized treatments for Parkinson's disease are newly introduced.
Therapies for multiple sclerosis are recently added offerings.
Funding Insights of Merz Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Merz Therapeutics
Merz Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Acorda. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Engaged in the development and commercialization of therapies that improve neurological function.
|
1995 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Merz Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Merz Therapeutics Comparisons
Competitors of Merz Therapeutics
Merz Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Incyte, NGM Biopharmaceuticals and Neurocrine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Merz Therapeutics
Where is Merz Therapeutics located?
Merz Therapeutics is headquartered in Frankfurt, Germany. It is registered at Frankfurt, Hesse, Germany.
What does Merz Therapeutics do?
Merz Therapeutics is engaged in the development and distribution of pharmaceutical solutions targeting chronic health conditions. The company specializes in therapeutic fields such as neurology, hepatology, and dermatology. Innovative treatments for movement disorders, Parkinsons disease, and multiple sclerosis are provided alongside patient-centric services. Operations span across multiple regions including Europe, the Middle East, and North America, with a commitment to sustainability and partnerships for enhanced patient outcomes.
Who are the top competitors of Merz Therapeutics?
Merz Therapeutics's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Merz Therapeutics offer?
Merz Therapeutics offers Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies.
How many acquisitions has Merz Therapeutics made?
Merz Therapeutics has made 1 acquisition, including Acorda.